Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

I. Saulite; Desislava Ignatova; Yun-Tsan Chang; C. Fassnacht; Florentia Dimitriou; E. Varypataki; Florian Anzengruber; M. Nägeli; Antonio Cozzio; Reinhard Dummer; J. Scarisbrick; Steve Pascolo; Wolfram Hötzenecker; Malgorzata Bobrowicz; Emmanuella Guenova

doi:10.1080/2162402X.2020.173

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

I. Saulite
, Desislava Ignatova
, Yun-Tsan Chang
, C. Fassnacht
, Florentia Dimitriou
, E. Varypataki
, Florian Anzengruber
, M. Nägeli
, Antonio Cozzio
, Reinhard Dummer
, J. Scarisbrick
, Steve Pascolo
, Wolfram Hötzenecker
, Malgorzata Bobrowicz
, Emmanuella Guenova

Department of Dermatology and Venereology

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1738797
Number of pages	1
Journal	OncoImmunology
Volume	18
Issue number	1
DOIs	https://doi.org/10.1080/2162402X.2020.173
Publication status	Published - 2020

Fields of science

302087 Venereology
302011 Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/2162402X.2020.173

Cite this

Saulite, I., Ignatova, D., Chang, Y.-T., Fassnacht, C., Dimitriou, F., Varypataki, E., Anzengruber, F., Nägeli, M., Cozzio, A., Dummer, R., Scarisbrick, J., Pascolo, S., Hötzenecker, W., Bobrowicz, M., & Guenova, E. (2020). Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. OncoImmunology, 18(1), Article 1738797. https://doi.org/10.1080/2162402X.2020.173

@article{9a73a9bc3ecd47f9a1068b82bfae32f9,

title = "Blockade of programmed cell death protein 1 (PD-1) in S{\'e}zary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation",

author = "I. Saulite and Desislava Ignatova and Yun-Tsan Chang and C. Fassnacht and Florentia Dimitriou and E. Varypataki and Florian Anzengruber and M. N{\"a}geli and Antonio Cozzio and Reinhard Dummer and J. Scarisbrick and Steve Pascolo and Wolfram H{\"o}tzenecker and Malgorzata Bobrowicz and Emmanuella Guenova",

year = "2020",

doi = "10.1080/2162402X.2020.173",

language = "English",

volume = "18",

journal = "OncoImmunology",

issn = "2162-402X",

number = "1",

}

Saulite, I, Ignatova, D, Chang, Y-T, Fassnacht, C, Dimitriou, F, Varypataki, E, Anzengruber, F, Nägeli, M, Cozzio, A, Dummer, R, Scarisbrick, J, Pascolo, S, Hötzenecker, W, Bobrowicz, M & Guenova, E 2020, 'Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation', OncoImmunology, vol. 18, no. 1, 1738797. https://doi.org/10.1080/2162402X.2020.173

TY - JOUR

T1 - Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

AU - Saulite, I.

AU - Ignatova, Desislava

AU - Chang, Yun-Tsan

AU - Fassnacht, C.

AU - Dimitriou, Florentia

AU - Varypataki, E.

AU - Anzengruber, Florian

AU - Nägeli, M.

AU - Cozzio, Antonio

AU - Dummer, Reinhard

AU - Scarisbrick, J.

AU - Pascolo, Steve

AU - Hötzenecker, Wolfram

AU - Bobrowicz, Malgorzata

AU - Guenova, Emmanuella

PY - 2020

Y1 - 2020

UR - https://www.scopus.com/pages/publications/85081935505

U2 - 10.1080/2162402X.2020.173

DO - 10.1080/2162402X.2020.173

M3 - Article

SN - 2162-402X

VL - 18

JO - OncoImmunology

JF - OncoImmunology

IS - 1

M1 - 1738797

ER -

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this